TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/26/24 16:15 | 4/17/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Haigh Adrian | NC | O | COO | M.am | 103 | 2.31 | 0 | 44 | New | 44 | D | ||||||||||||||
4/26/24 16:10 | 4/15/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Haigh Adrian | NC | O | COO | M.am | 103 | 2.31 | 0 | 44 | New | 44 | D | ||||||||||||||
4/22/24 19:34 | 4/19/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Haigh Adrian | NC | O | COO | M.dm | 103 | 2.31 | 0 | 44 | 0 | D | |||||||||||||||
4/22/24 19:34 | 4/19/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Haigh Adrian | NC | O | COO | S.dm | -414 | 9.33 | 0 | -44 | -100 | 0 | D | ||||||||||||||
4/18/24 21:43 | 4/17/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Haigh Adrian | NC | O | COO | S.dm | -537 | 6.04 | 0 | -89 | -100 | 0 | D | ||||||||||||||
4/16/24 18:00 | 4/15/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Haigh Adrian | NC | O | COO | S.dm | -560 | 6.30 | 0 | -89 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |